7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D011464:Epoprostenol / Q000378:metabolism*; D006168:Guinea Pigs; D009119:Muscle Contraction / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000378:metabolism*; D011956:Receptors, Cell Surface / Q000378:metabolism*; D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin / Q000187:drug effects / Q000378:metabolism*; D017482:Receptors, Thromboxane; D013329:Structure-Activity Relationship; D013928:Thromboxane A2 / Q000031:analogs & derivatives / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors; D013931:Thromboxanes / Q000494:pharmacology*; D014132:Trachea / Q000187:drug effects
D011453:Prostaglandins; D011956:Receptors, Cell Surface; D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin; D017482:Receptors, Thromboxane; D013931:Thromboxanes; D013928:Thromboxane A2; D011464:Epoprostenol; D000262:Adenylyl Cyclases; D013930:Thromboxane-A Synthase